Global Preventive Asthma Drugs Sales Market Report 2017

August 2017 | 124 pages | ID: GCE7C8E768EEN
QYResearch

Abstracts

In this report, the global Preventive Asthma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Preventive Asthma Drugs for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Preventive Asthma Drugs market competition by top manufacturers/players, with Preventive Asthma Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• F. Hoffmann-La Roche
• GlaxoSmithKline?
• Merck
• Novartis?
• Abbott
• Amgen
• AptarGroup
• Biotest
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cytos
• Dainippon Sumitomo
• Medicinova
• Mylan
• Novartis
• Orchid Chemicals and Pharmaceuticals
• Pfizer
• Rottapharm Madaus
• Skyepharma
• Sosei
• Sunovion
• Teva Pharmaceutical?
• Theravance
• Vectura ?

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Immunosuppressants?
• Leukotriene antagonists
• Mast cell stabilizers
• Corticosteroids
• Combination of LABA/ ICS

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Preventive Asthma Drugs for each application, including

• Children
• Adult

Contents

Global Preventive Asthma Drugs Sales Market Report 2017

1 PREVENTIVE ASTHMA DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Preventive Asthma Drugs
1.2 Classification of Preventive Asthma Drugs by Product Category
  1.2.1 Global Preventive Asthma Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Preventive Asthma Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Immunosuppressants?
  1.2.4 Leukotriene antagonists
  1.2.5 Mast cell stabilizers
  1.2.6 Corticosteroids
  1.2.7 Combination of LABA/ ICS
1.3 Global Preventive Asthma Drugs Market by Application/End Users
  1.3.1 Global Preventive Asthma Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Children
  1.3.3 Adult
1.4 Global Preventive Asthma Drugs Market by Region
  1.4.1 Global Preventive Asthma Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Preventive Asthma Drugs Status and Prospect (2012-2022)
  1.4.3 China Preventive Asthma Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Preventive Asthma Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Preventive Asthma Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Preventive Asthma Drugs Status and Prospect (2012-2022)
  1.4.7 India Preventive Asthma Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Preventive Asthma Drugs (2012-2022)
  1.5.1 Global Preventive Asthma Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Preventive Asthma Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL PREVENTIVE ASTHMA DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Preventive Asthma Drugs Market Competition by Players/Suppliers
  2.1.1 Global Preventive Asthma Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Preventive Asthma Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Preventive Asthma Drugs (Volume and Value) by Type
  2.2.1 Global Preventive Asthma Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Preventive Asthma Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Preventive Asthma Drugs (Volume and Value) by Region
  2.3.1 Global Preventive Asthma Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Preventive Asthma Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Preventive Asthma Drugs (Volume) by Application

3 UNITED STATES PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Preventive Asthma Drugs Sales and Value (2012-2017)
  3.1.1 United States Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Preventive Asthma Drugs Sales Price Trend (2012-2017)
3.2 United States Preventive Asthma Drugs Sales Volume and Market Share by Players
3.3 United States Preventive Asthma Drugs Sales Volume and Market Share by Type
3.4 United States Preventive Asthma Drugs Sales Volume and Market Share by Application

4 CHINA PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Preventive Asthma Drugs Sales and Value (2012-2017)
  4.1.1 China Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Preventive Asthma Drugs Sales Price Trend (2012-2017)
4.2 China Preventive Asthma Drugs Sales Volume and Market Share by Players
4.3 China Preventive Asthma Drugs Sales Volume and Market Share by Type
4.4 China Preventive Asthma Drugs Sales Volume and Market Share by Application

5 EUROPE PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Preventive Asthma Drugs Sales and Value (2012-2017)
  5.1.1 Europe Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Preventive Asthma Drugs Sales Price Trend (2012-2017)
5.2 Europe Preventive Asthma Drugs Sales Volume and Market Share by Players
5.3 Europe Preventive Asthma Drugs Sales Volume and Market Share by Type
5.4 Europe Preventive Asthma Drugs Sales Volume and Market Share by Application

6 JAPAN PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Preventive Asthma Drugs Sales and Value (2012-2017)
  6.1.1 Japan Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Preventive Asthma Drugs Sales Price Trend (2012-2017)
6.2 Japan Preventive Asthma Drugs Sales Volume and Market Share by Players
6.3 Japan Preventive Asthma Drugs Sales Volume and Market Share by Type
6.4 Japan Preventive Asthma Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Preventive Asthma Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Preventive Asthma Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Preventive Asthma Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Preventive Asthma Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Preventive Asthma Drugs Sales Volume and Market Share by Application

8 INDIA PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Preventive Asthma Drugs Sales and Value (2012-2017)
  8.1.1 India Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Preventive Asthma Drugs Sales Price Trend (2012-2017)
8.2 India Preventive Asthma Drugs Sales Volume and Market Share by Players
8.3 India Preventive Asthma Drugs Sales Volume and Market Share by Type
8.4 India Preventive Asthma Drugs Sales Volume and Market Share by Application

9 GLOBAL PREVENTIVE ASTHMA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 AstraZeneca
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 AstraZeneca Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 F. Hoffmann-La Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 F. Hoffmann-La Roche Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline?
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 GlaxoSmithKline? Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Merck
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Merck Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Novartis?
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Novartis? Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Abbott
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Abbott Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Amgen
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Amgen Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 AptarGroup
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 AptarGroup Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Biotest
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Biotest Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Boehringer Ingelheim
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Preventive Asthma Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Boehringer Ingelheim Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Chiesi Farmaceutici
9.12 Cytos
9.13 Dainippon Sumitomo
9.14 Medicinova
9.15 Mylan
9.16 Novartis
9.17 Orchid Chemicals and Pharmaceuticals
9.18 Pfizer
9.19 Rottapharm Madaus
9.20 Skyepharma
9.21 Sosei
9.22 Sunovion
9.23 Teva Pharmaceutical?
9.24 Theravance
9.25 Vectura ?

10 PREVENTIVE ASTHMA DRUGS MAUFACTURING COST ANALYSIS

10.1 Preventive Asthma Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Preventive Asthma Drugs
10.3 Manufacturing Process Analysis of Preventive Asthma Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Preventive Asthma Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Preventive Asthma Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PREVENTIVE ASTHMA DRUGS MARKET FORECAST (2017-2022)

14.1 Global Preventive Asthma Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Preventive Asthma Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Preventive Asthma Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Preventive Asthma Drugs Price and Trend Forecast (2017-2022)
14.2 Global Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Preventive Asthma Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Preventive Asthma Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Preventive Asthma Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Preventive Asthma Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Preventive Asthma Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Preventive Asthma Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Preventive Asthma Drugs Price Forecast by Type (2017-2022)
14.4 Global Preventive Asthma Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Preventive Asthma Drugs
Figure Global Preventive Asthma Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Preventive Asthma Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunosuppressants? Product Picture
Figure Leukotriene antagonists Product Picture
Figure Mast cell stabilizers Product Picture
Figure Corticosteroids Product Picture
Figure Combination of LABA/ ICS Product Picture
Figure Global Preventive Asthma Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Preventive Asthma Drugs by Application in 2016
Figure Children Examples
Figure Adult Examples
Figure Global Preventive Asthma Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Preventive Asthma Drugs Sales Volume (K Units) (2012-2017)
Table Global Preventive Asthma Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Preventive Asthma Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Preventive Asthma Drugs Sales Share by Players/Suppliers
Figure 2017 Preventive Asthma Drugs Sales Share by Players/Suppliers
Figure Global Preventive Asthma Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Preventive Asthma Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Preventive Asthma Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Preventive Asthma Drugs Revenue Share by Players
Table 2017 Global Preventive Asthma Drugs Revenue Share by Players
Table Global Preventive Asthma Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Preventive Asthma Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Preventive Asthma Drugs by Type (2012-2017)
Figure Global Preventive Asthma Drugs Sales Growth Rate by Type (2012-2017)
Table Global Preventive Asthma Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Preventive Asthma Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Preventive Asthma Drugs by Type (2012-2017)
Figure Global Preventive Asthma Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Preventive Asthma Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Preventive Asthma Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Preventive Asthma Drugs by Region (2012-2017)
Figure Global Preventive Asthma Drugs Sales Growth Rate by Region in 2016
Table Global Preventive Asthma Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Preventive Asthma Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Preventive Asthma Drugs by Region (2012-2017)
Figure Global Preventive Asthma Drugs Revenue Growth Rate by Region in 2016
Table Global Preventive Asthma Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Preventive Asthma Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Preventive Asthma Drugs by Region (2012-2017)
Figure Global Preventive Asthma Drugs Revenue Market Share by Region in 2016
Table Global Preventive Asthma Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Preventive Asthma Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Preventive Asthma Drugs by Application (2012-2017)
Figure Global Preventive Asthma Drugs Sales Market Share by Application (2012-2017)
Figure United States Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Preventive Asthma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Preventive Asthma Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Preventive Asthma Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Preventive Asthma Drugs Sales Volume Market Share by Players in 2016
Table United States Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Preventive Asthma Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Preventive Asthma Drugs Sales Volume Market Share by Type in 2016
Table United States Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Preventive Asthma Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Preventive Asthma Drugs Sales Volume Market Share by Application in 2016
Figure China Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Preventive Asthma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Preventive Asthma Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Preventive Asthma Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Preventive Asthma Drugs Sales Volume Market Share by Players in 2016
Table China Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Preventive Asthma Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Preventive Asthma Drugs Sales Volume Market Share by Type in 2016
Table China Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Preventive Asthma Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Preventive Asthma Drugs Sales Volume Market Share by Application in 2016
Figure Europe Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Preventive Asthma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Preventive Asthma Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Preventive Asthma Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Preventive Asthma Drugs Sales Volume Market Share by Players in 2016
Table Europe Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Preventive Asthma Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Preventive Asthma Drugs Sales Volume Market Share by Type in 2016
Table Europe Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Preventive Asthma Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Preventive Asthma Drugs Sales Volume Market Share by Application in 2016
Figure Japan Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Preventive Asthma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Preventive Asthma Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Preventive Asthma Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Preventive Asthma Drugs Sales Volume Market Share by Players in 2016
Table Japan Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Preventive Asthma Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Preventive Asthma Drugs Sales Volume Market Share by Type in 2016
Table Japan Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Preventive Asthma Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Preventive Asthma Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Preventive Asthma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Preventive Asthma Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Preventive Asthma Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Preventive Asthma Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Preventive Asthma Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Preventive Asthma Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Preventive Asthma Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Preventive Asthma Drugs Sales Volume Market Share by Application in 2016
Figure India Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Preventive Asthma Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Preventive Asthma Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Preventive Asthma Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Preventive Asthma Drugs Sales Volume Market Share by Players in 2016
Table India Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Preventive Asthma Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Preventive Asthma Drugs Sales Volume Market Share by Type in 2016
Table India Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Preventive Asthma Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Preventive Asthma Drugs Sales Volume Market Share by Application in 2016
Table AstraZeneca Basic Information List
Table AstraZeneca Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure AstraZeneca Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline? Basic Information List
Table GlaxoSmithKline? Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline? Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline? Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline? Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure Merck Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure Merck Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Novartis? Basic Information List
Table Novartis? Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis? Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure Novartis? Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure Novartis? Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure Abbott Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure Abbott Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure Amgen Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure Amgen Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table AptarGroup Basic Information List
Table AptarGroup Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AptarGroup Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure AptarGroup Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure AptarGroup Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Biotest Basic Information List
Table Biotest Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotest Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure Biotest Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure Biotest Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Preventive Asthma Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Preventive Asthma Drugs Sales Global Market Share (2012-2017
Figure Boehringer Ingelheim Preventive Asthma Drugs Revenue Global Market Share (2012-2017)
Table Chiesi Farmaceutici Basic Information List
Table Cytos Basic Information List
Table Dainippon Sumitomo Basic Information List
Table Medicinova Basic Information List
Table Mylan Basic Information List
Table Novartis Basic Information List
Table Orchid Chemicals and Pharmaceuticals Basic Information List
Table Pfizer Basic Information List
Table Rottapharm Madaus Basic Information List
Table Skyepharma Basic Information List
Table Sosei Basic Information List
Table Sunovion Basic Information List
Table Teva Pharmaceutical? Basic Information List
Table Theravance Basic Information List
Table Vectura ? Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Preventive Asthma Drugs
Figure Manufacturing Process Analysis of Preventive Asthma Drugs
Figure Preventive Asthma Drugs Industrial Chain Analysis
Table Raw Materials Sources of Preventive Asthma Drugs Major Players in 2016
Table Major Buyers of Preventive Asthma Drugs
Table Distributors/Traders List
Figure Global Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Preventive Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Preventive Asthma Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Preventive Asthma Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Preventive Asthma Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Preventive Asthma Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Preventive Asthma Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Preventive Asthma Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Preventive Asthma Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Preventive Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Preventive Asthma Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Preventive Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Preventive Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Preventive Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Preventive Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Preventive Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Preventive Asthma Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Preventive Asthma Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Preventive Asthma Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Preventive Asthma Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Preventive Asthma Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Preventive Asthma Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Preventive Asthma Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources